TIDEGLUSIB

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H14N2O2S
Molecular Weight	334.392
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O=C1SN(C(=O)N1CC2=CC=CC=C2)C3=CC=CC4=C3C=CC=C4

InChI

InChIKey=PMJIHLSCWIDGMD-UHFFFAOYSA-N

InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2

HIDE SMILES / InChI

Molecular Formula	C19H14N2O2S
Molecular Weight	334.392
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22102280 | https://www.ncbi.nlm.nih.gov/pubmed/24532007

Tideglusib (NP031112, NP-12, Nypta, Noscira SA, Madrid, Spain), a drug, which belongs to the thiadiazolidinone family, is a GSK-3β inhibitor. Tideglusib was in phase II clinical trials for the treatment of Alzheimer disease (AD) and progressive supranuclear palsy. Participants showed no benefit on either of the primary outcome measures or exploratory endpoints and further development in the drug was halted for these two disease. However, Tideglusib is on phase II clinical trial to determine whether drug is safe and efficacious in the treatment of adolescents and adults with congenital and juvenile-onset Myotonic Dystrophy.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Glycogen synthase kinase-3 beta 51 Target ID: P49841 Gene ID: 2932.0 Gene Symbol: GSK3B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22102280	Inhibitor 8297

Conditions

Condition	Modality	Highest Phase	Product
Alzheimer’s disease 272 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22936007	Primary	Phase II 1132	Unknown Approved Use Unknown
Progressive supranuclear palsy 3 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24488721	Primary	Phase II 1132	Unknown Approved Use Unknown
Myotonic dystrophy 1 Sources: https://clinicaltrials.gov/ct2/show/NCT02858908	Primary	Phase II 1132	Unknown Approved Use Unknown

Sourcing

Vendor/Aggregator	ID	URL
1PlusChem LLC	1P0036M4	https://www.1pchem.com/search?query=1P0036M4
AChemBlock	O32866	http://www.achemblock.com/catalogsearch/result/?q=O32866
AK Scientific	X5395	https://aksci.com/item_detail.php?cat=X5395
AOBIOUS INC	AOB5562	http://aobious.com/aobious/search?search_query=AOB5562
Angene	AGN-PC-006L53	http://www.angenechemical.com/productshow/AGN-PC-006L53.html
ApexBio Technology	B1539	https://www.apexbt.com/catalogsearch/result/?q=B1539
AstaTech	40613	http://astatechinc.com/CPSResult.php?CRNO=40613
BLD Pharm	BD306015	http://www.bldpharm.com/search/Search.html?keyword=BD306015
BOC Sciences	865854-05-3	http://www.bocsci.com/description.asp?cas=865854-05-3
Cayman Chemical	16727	http://www.caymanchem.com/app/template/Product.vm/catalog/16727
Chem Scene	CS-0613	http://www.chemscene.com/goproductList/searchProductList?productObj=CS-0613
ChemShuttle	104792	https://www.chemshuttle.com/catalogsearch/result/?q=104792
Debye Scientific	DA-41071	https://www.debyesci.com/index.php?id=product&ext[cno]=DA-41071
Excenen	EX-A600	http://www.excenen.com/searchresultlist.php?id=EX-A600
KeyOrganics	AS-56156	http://www.keyorganicsinc.com/bionet/catalogsearch/result?q=AS-56156
Lab Network	LN01314805	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01314805
Matrix Scientific	145196	http://www.matrixscientific.com/145196.html
MedChem Express	HY-14872	https://www.medchemexpress.com/search.html?q=HY-14872&ft=&fa=&fp=
MolPort	MolPort-028-599-952	https://www.molport.com/shop/molecule-link/MolPort-028-599-952
Molnova	M16292	https://www.molnova.com/en/serch-list.html?keywords=M16292
MuseChem	I005208	https://www.musechem.com/product/I005208.html
Selleck Chemicals	S2823	http://www.selleckchem.com/search.html?searchDTO.searchParam=S2823
ShangHai Biochempartner	BCP000647	http://www.biochempartner.com/search_BCP000647
ShangHai Biochempartner	BCP06016	http://www.biochempartner.com/search_BCP06016
TargetMol	T3067	https://www.targetmol.com/search?keyword=T3067
Wonderchem	WC-009UNT	http://www.wonder-chem.com/search.html?text=WC-009UNT
eMolecules	44786343	https://orderbb.emolecules.com/search/#?query=44786343
eNovation Chemicals	D480521	https://www.enovationchem.com/Products.asp?SEARCHTEXT=D480521&searchbtn.x=0&searchbtn.y=0
mcule	MCULE-3900652558	https://mcule.com/MCULE-3900652558/

PubMed

Title	Date	PubMed
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.	2011	21760986
Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities.	2011 Dec 22	22050263
Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study.	2013	22936007

Patents

Sample Use Guides

In Vivo Use Guide

1000 mg of tideglusib as a powder for oral suspension once every other day in an overnight fasted state for 26 weeks/extension

Route of Administration: Oral

In Vitro Use Guide

Tideglusib is an irreversible inhibitor of GSK-3β. The interaction of tideglusib with GSK-3β, binding studies with radioactive compound were performed. [35S]tideglusib (207 Bq/nmol) at 55 μM was incubated with 5 μM GSK-3β for 1 h at 25 °C in 315 μl of 50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl and 0.1 mM EGTA.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:25:10 UTC 2023` Edited by `admin` on `Fri Dec 15 17:25:10 UTC 2023`
Record UNII	Q747Y6TT42
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TIDEGLUSIB

Official Name

English

4-BENZYL-2-(A-NAPHTHYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE

Common Name

English

NP-031112

Code

English

NP-12

Code

English

4-BENZYL-2-(A-NAPHTYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE

Common Name

English

4-BENZYL-2-(NAPHTHALEN-1-YL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE

Systematic Name

English

tideglusib [INN]

Common Name

English

NP031112

Code

English

Tideglusib [WHO-DD]

Common Name

English

Classification Tree Code System Code

EU-Orphan Drug

EU/3/15/1452